MedAscend buys dot-md in multimillion-dollar deal

Article

MedAscend, a healthcare software firm based in Atlanta, has purchased the rights to manage the Internet domain .md (dot-md) and has changed its name to dotMD. The complicated deal included negotiating with the country of Moldova and acquiring

MedAscend, a healthcare software firm based in Atlanta, has purchased the rights to manage the Internet domain .md (dot-md) and has changed its name to dotMD. The complicated deal included negotiating with the country of Moldova and acquiring Domain Name Trust, a company that had previously purchased the rights to sell Internet addresses on the dot-md domain from Moldova. dotMD has also settled a lawsuit brought by a handful of companies that had already been given the rights to sell dot-md addresses. As part of the deal with Moldova, dotMD has offered the government of Moldova a 5% equity stake in the company and an undisclosed royalty rate for all dot-md registrations.


© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 7.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.